ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1244

Incidence of Radiographic Spinal Damage in Psoriatic Arthritis Patients Compared to Spondyloarthritis Patients: Which Patients Are More Affected?

Manouk de Hooge1, Alla Alexeevna Ishchenko2, Ann-Sophie Kathleen De Craemer3, Serge Steinfeld4, Adrien NZEUSSEU TOUKAP5, Filip Van den bosch6, Dirk Elewaut7, Rik Lories8 and Kurt de Vlam9, 1Ghent University Hospital, Luxembourg, Luxembourg, 2University Hospitals Leuven, Sint-Stevens-Woluwe, Belgium, 3Ghent University Hospital, Gent, Belgium, 4Clinique Saint-Jean, Brussels, Belgium, 5Cliniques Universitaires Saint-Luc, Brussels, Belgium, 6Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium, 7Department of Rheumatology, Ghent University Hospital, Belgium, VIB-UGent Center for Inflammation Research, Ghent University, Heusden, Belgium, 8KU Leuven, Leuven, Belgium, 9University Hospitals Leuven, Leuven, Belgium

Meeting: ACR Convergence 2022

Keywords: Cohort Study, Imaging, Psoriatic arthritis, radiography, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: There is an ongoing debate on axial involvement in psoriatic arthritis (PsA) patients. This study reports the baseline radiographic spinal damage in PsA and SpA patients from 2 prospective multicentre cohort studies in private and academic rheumatology practices.

Methods: PsA patients originated from the Belgian Epidemiological Psoriatic Arthritis Study (BEPAS), a prospective multicentre cohort involving 17 Belgian rheumatology practices. Recruitment was from December 2012 until July 2014. Patients were included when patients fulfilled the Classification criteria for Psoriatic Arthritis (CASPAR). Radiographs of the spine were obtained at baseline and after 2 years. Two calibrated readers evaluated radiographic damage by assessing the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). When assessing images, readers were blinded for time sequence, clinical data and information from other obtained images (radiographs of the hands and feet).

Results: In total 461 patients were included in BEPAS. Mean age 52.79±12.29 years and 43.0% (n=198) were female; average disease duration was 8.5 ± 9.3 years and approximately 34% of the patients reported inflammatory axial pain. From 312 patients spinal radiographs were obtained. At baseline, the vast majority of PsA patients had an mSASSS of 0 (n=273, 87.5%), according to both readers. In 33 PsA patients (10.6%) mSASSS was 2 or more. For SpA patients, percentages were lower but the trend was similar (see figure 1). Though lesser patients showed abnormalities, SpA patients with spinal damage show a higher mSASSS, therefore indicating more spinal damage then the PsA patients (p< 0.05). Both patient groups show some outliers with high mSASSS, increasing the average mSASSS especially in the SpA cohort (mean mSASSS = 10.3±14.91) compared to the median of 5 (IQR 2-13) in the Be-Giant and 3 (IQR 2-6) in the BEPAS cohort. Syndesmophytes are seen in 10.6% and 6.6% of the PsA and SpA patients, respectively. Similar to the mSASSS, SpA patients had more syndesmophytes (mean: 4.9±5.78) compared to PsA patients (mean 2.0±1.45); p< 0.05.PsA patients had more often syndesmophytes located in the cervical spine; 24/33 patients (72.7%) compared to 11/33 (33.3%) patients with lumbar syndesmophytes. Syndesmophyte location was more evenly distributed in SpA patients; cervical 9/14 (64.3.9%) and lumbar 10/14 (71.4%). Percentages exceed 100%, as there were patients with syndesmophytes in both spinal segments.Erosions and especially sclerosis and squaring are uncommon in both patient groups.

Conclusion: Spinal damage is seen in approximately 10% or less of both PsA and SpA patients in these cohorts. SpA patients show higher mSASSS values and more syndesmophytes as compared to the PsA patients. Syndesmophytes in PsA patients are more often located in the cervical spine while the location is more equally distributed in SpA patients.

Supporting image 1


Disclosures: M. de Hooge, None; A. Ishchenko, None; A. De Craemer, None; S. Steinfeld, None; A. NZEUSSEU TOUKAP, None; F. Van den bosch, AbbVie, Lilly, Galapagos, Janssen, Merck, Novartis, Pfizer, UCB, Amgen, Bristol-Myers Squibb(BMS), Celgene; D. Elewaut, AbbVie, Eli Lilly, Galapagos, Novartis, UCB Pharma; R. Lories, None; K. de Vlam, UCB, Eli Lilly, Pfizer, AbbVie/Abbott, Merck/MSD, johnson and johnson.

To cite this abstract in AMA style:

de Hooge M, Ishchenko A, De Craemer A, Steinfeld S, NZEUSSEU TOUKAP A, Van den bosch F, Elewaut D, Lories R, de Vlam K. Incidence of Radiographic Spinal Damage in Psoriatic Arthritis Patients Compared to Spondyloarthritis Patients: Which Patients Are More Affected? [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/incidence-of-radiographic-spinal-damage-in-psoriatic-arthritis-patients-compared-to-spondyloarthritis-patients-which-patients-are-more-affected/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-radiographic-spinal-damage-in-psoriatic-arthritis-patients-compared-to-spondyloarthritis-patients-which-patients-are-more-affected/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology